Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 1 | Respiratory Research

Figure 1

From: Fluticasone propionate/salmeterol 250/50 μg versus salmeterol 50 μg after chronic obstructive pulmonary disease exacerbation

Figure 1

Chronological schematic of experimental design.Note: 1. Duration of index hospitalization is ≤10 days. Time from hospital discharge, ER, or physician’s office visit (due to the recent exacerbation) to Randomization (Visit 2) is ≤14 days. Visit 1 (Screening) and Visit 2 can occur during the hospitalization, ER visit, physician’s office visit, and up to 14 days afterward. 2. Duration of subjects’ participation in study is 29 weeks (completing subjects), approximately (unless subject is prematurely withdrawn from the study). ER: Emergency Room; F/U: Follow-up; TC: Telephone call; V: Visit; Wks: Weeks.

Back to article page